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Treatment of acute seizures in children requires prompt medical attention, ventila-
tion support and appropriate oxygenation until they either stop spontaneously or are
controlled by drugs. Benzodiazepines (BZD) are considered to be the treatment of choice
for acute management of severe seizures. BZDs are active against a wide range of sei-
zure types, have a rapid onset of action once delivered into the central nervous system,
and are safe (1, 2). Diazepam (DZP) is a long-acting benzodiazepine with anticonvulsant,
anxiolytic, sedative muscle relaxant and amnesic properties and it is the most widely
used drug for treatment of insomnia, febrile convulsions, status epilepticus and alcohol
withdrawal symptoms (3). However, it has a short duration of action, and should be giv-
en intravenously or rectally (since its absorption is slow if given intramuscularly). Oral
and sublingual administration is frequently difficult, impossible, or hazardous when the
patient is actively having a seizure or is in the postictal state. Also, absorption after oral
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Diazepam (DZP) has become a commonly used drug for
treatment of acute repetitive epileptic seizures and febrile
convulsions in children. Considering the advantages of
rectal administration of DZP, the objective of our study
was to formulate and evaluate rectal hydrogels contain-
ing DZP as a drug substance in combination with suit-
able co-solvents and preservatives.
Prepared HPMC (hydroxypropyl methylcellulose) hydro-
gels containing different concentrations of DZP (2, 4 and
6 mg mL–1) manifested good quality in respect to physico-
-chemical parameters (pH value, drug content, ingredi-
ents content and viscosity), antimicrobial efficiency and
microbiological quality. Under the proposed HPLC condi-
tions, satisfactory separation of DZP and the preservatives
used was achieved. In vitro release studies have shown
that the total amount of DZP was released in a period of
3 h. Prepared formulations were stable for four months
at 26 °C (ambient temperature characteristic of the 2nd
climate zone).
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administration of tablets is usually slower than after parenteral or rectal administration.
Introduction of an intravenous line may also be difficult, particularly in children with
generalized tonic-clonic febrile seizures (4, 5). Rectal administration of DZP is now wi-
dely employed and could be as effective as the intravenous route (6). Also, nonmedical
personnel, irrespective of the patient’s ability to cooperate, can administer rectal prepa-
rations easily and safely (7, 8).
Rectal DZP solutions have many characteristics sought in the ideal drug to treat
acute repetitive seizures (9). Their high lipid solubility permits both prompt absorption
and rapid penetration into the central nervous system. In children, the peak serum plas-
ma concentration was reached within 3 to 30 minutes, with bioavailability averaging be-
tween 80 and 100% (10). In contrast, diazepam suppositories have slow, erratic absorp-
tion, which limits their use in the management of acute seizures (11).
In general, dosage forms designed for rectal administration should not cause irrita-
tion, should show good retention in the lower region of the large intestine, and should
be suitable enough to be accepted by the patient. These requirements can be met by us-
ing hydrogels, having in mind that rectal solutions tend to leak out of the rectum, lead-
ing to inaccurate dosing and treatment failure (12).
A hydrogel is a three-dimensional network of hydrophilic polymer chains that could
be cross-linked through either chemical or physical bonding. Because of the hydrophilic
nature of polymer chains, hydrogels are capable of swelling when placed in aqueous
media, i.e., they retain a significant amount of water but remain water-insoluble (13, 14).
When a drug substance is loaded into such a hydrogel, the diffusion rate of the drug de-
pends on the physical structure of the polymer network and its chemical nature. If the
hydrogel is highly hydrated, diffusion occurs through the pores within the gel network.
In gels of lower hydration, the drug dissolves in the polymer and is transported be-
tween the chains. When the polymers are cross-linked, the hydrophobicity of a gel is in-
creased and the diffusion rate of the drug is diminished (15). These characteristics of
hydrogels, as well as their biocompatibility, increased duration of action with increased
therapeutical efficiency due to the viscosity of the gel matrix and soft consistency (easy
and safe administration at home by nonmedical persons) could be considered a poten-
tially beneficial approach in the formulation of rectal forms of DZP.
Considering all the above mentioned facts, we have formulated a DZP rectal hy-
drogel using a contemporary approach in designing hydrogel preparations.
EXPERIMENTAL
Materials
Diazepam (DZP) was provided by FIS – SpA (Italy). The gelling agent hydroxypro-
pyl methylcellulose (HPMC-E5) was purchased from Hercules (Methocel E 5, USA). The
antimicrobial preservatives (benzyl alcohol, benzoic acid and sodium benzoate), ethanol
and propylene glycol were supplied by Alkaloid, Macedonia. All other materials were of
analytical grade.
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Methods
Preparation of DZP rectal gels. – Rectal hydrogels containing different concentrations
of DZP: 2 mg mL–1 (sample HG1), 4 mg mL–1 (sample HG2) and 6 mg mL–1 (sample
HG3) were prepared by incorporation of the DZP solution into a structured vehicle of
HPMC-E5 (15%, m/V).
The basic solvent in the formulation was deionized water but the solubility of DZP
in water is 0.05 mg mL–1. For this reason, the mixture of co-solvents (ethanol/propylene
glycol 1:3, V/V) was used in concentrations allowed for parenteral solutions (16) (Table I).
In short, the antimicrobial preservatives (benzyl alcohol, benzoic acid and sodium
benzoate, the combination of preservatives commonly used into commercial rectal solu-
tions of DZP – Stesolit®, Valium®, Desitin®) were dissolved in co-solvents present in the
formulation according to their solubility, i.e., benzyl alcohol was dissolved in ethanol
and then the benzoic acid was added. Sodium benzoate was dissolved in deionized wa-
ter. The drug substance was dissolved in the prepared mixture of co-solvents and anti-
microbial preservatives. Afterwards, it was incorporated into the structured vehicle of
HPMC E5 by gentle mechanical stirring (25 rpm, 2 min), so the final concentration of
DZP in hydrogels was 2, 4 and 6 mg mL–1, respectively. The gel base, the structured ve-
hicle of HPMC E5, was prepared by the »hot/cold« technique (17).
Prepared formulations were packed into 2.5-mL polyethylene containers provided
with a suitable applicator for rectal administration and were stored in the stability chamb-
er (Köttermann 2391, Köttermann, Germany) for 4 months at 26 °C protected from light.
Evaluation of the formulations
pH value was determined according to the method proposed by European Pharmaco-
poeia (pH meter Jenway 3310, UK) (18).
Drug content in rectal hydrogels. – The DZP and preservatives content was determined
using the reverse-phase HPLC technique by the external standard method (19). Analyses
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Table I. Diazepam hydrogel preparation























were performed on a Waters HPLC system, equipped with Waters 600 E pump, sample
injector Rheodyne 7725i with 20-mL loop and Waters 996 photodiode array detector. The
column used was LiChrospher® 60, RP Selected B, 125 x 4 mm i.d., 5-m particles (Merck,
Germany). The chromatographic conditions were: mobile phase – methanol and phosphate
buffer pH 2.5 in a ratio 44:56 (V/V), flow rate – 1 mL min–1 and UV detection at 254 nm.
Prepared DZP rectal hydrogel (1 mL) was transferred to a volumetric flask of 20 mL,
10 mL of methanol was added, and the flask was placed in the ultrasonic bath for 30
min. After cooling at ambient temperature, the flask was filled with methanol to the vol-
ume. The sample was centrifuged on 3000 rpm for 15 min. Clear centrifugate (5 mL) was
transferred to a 10-mL volumetric flask and filled with mobile phase to the volume. After
filtration through 0.45-µm membrane filter, an aliquot of sample solution was injected
into the HPLC system. Empty hydrogel – blank solution (without DZP and preserva-
tives) was also prepared and analyzed by to the same procedure.
The content of other ingredients, such as benzyl alcohol, benzoic acid/sodium ben-
zoate were determined under the same chromatographic conditions.
Rheological studies. – Viscosity determinations of the prepared formulations were
carried out using a rotational viscometer with coaxial cylinders (Haake RV3, Sensor sys-
tem MVI, Haake, Germany). Viscosity of the gels was measured at different angular ve-
locities at a temperature of 23 ± 1 °C and then the temperature was raised to 37 ± 1 °C. A
typical run comprised changing of the angular velocity from 0.5 to 110 rpm at a con-
trolled ramp speed. The hierarchy of angular velocity was reversed. The average of three
readings was used to calculate the viscosity. Flow behaviour was analyzed by regression
analysis of the log-log plots of shear stress vs. shear rate.
In vitro release studies. – A known quantity of the prepared rectal hydrogel (1 g) was
poured in a glass tube in the presence of phosphate buffer pH 7.4 (10 mL). In vivo condi-
tions were simulated in a horizontal shaker bath (37 ± 1 °C, 75 strikes min–1; Haake SWB
20, Haake, Germany). Aliquots were taken at regular time intervals and were replaced
by an equal volume of prewarmed phosphate buffer. Withdrawn aliquots were analyzed
spectrophotometrically at 316 nm (Lambda 16, Perkin Elmer, USA). All experiments were
carried out in triplicate and average values are presented.
Antimicrobial preservation and microbiological quality of hydrogels. – The efficacy of anti-
microbial preservation by preservatives was assessed according to the method given in
European Pharmacopoeia (18). Test microorganisms were Candida albicans (NCPF 3179),
Pseudomonas aeruginosa (CIP 82.118) and Escherichia coli (CIP 53.126). Ten mL of the pre-
paration were inoculated with 0.1 mL bacterial suspension and the number of microor-
ganisms was counted in a blood-agar medium over a period of 7, 14 and 28 days. The
following log values are adequate for the microorganisms of interest according to the
European Pharmacopoeia (18), criteria B for topical preparations: 3 for bacteria and 1 for
fungus during 14 days without growth increase for 28 days.
The microbiological quality of the prepared rectal hydrogels was tested according to
the method stated in European Pharmacopoeia (category 3) (18). Sampling plan was car-
ried out using the procedure for microbiological examination of non-sterile (water-solu-
ble) products. The total count of viable microorganisms (Candida albicans and Escherichia
coli) was determined by the plate-count method.
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Stability of DZP rectal hydrogels. – Stability was evaluated by maintaining the formu-
lations at a temperature of 2–8 °C and 37 ± 0.5 °C over a period of 1 month. The prepara-
tions were maintained over a period of 4 months at a temperature of 26 ± 0.5 °C, ambient
temperature characteristic of the 2nd climate zone (21). Physicochemical parameters such
as pH value, drug and ingredients content, viscosity and microbiological quality were
determined periodically after the 1st, 2nd, 3rd and 4th month after hydrogels preparation.
RESULTS AND DISCUSSION
Evaluation of DZP rectal hydrogels
The prepared DZP rectal hydrogel formulations were clear, light-yellowish homoge-
neous gels. The physico-chemical parameters of freshly prepared formulations are pre-
sented in Table II. Concerning the pH value, viscosity and preservatives content, no sig-
nificant changes between the prepared hydrogels (HG1, HG2 and HG3) were observed.
Drug content in rectal hydrogels. – Although many HPLC methods have been devel-
oped for quantitative determination of DZP in various materials and dosage forms, such
as blood, plasma, urine, tablets and injections (22–25), no HPLC method for determina-
tion of DZP in HPMC hydrogels has been reported in literature.
From the chromatograms of standard solution, blank solution (empty hydrogel so-
lution) and sample solution (for formulation HG1) presented in Fig. 1, it is evident that
under the proposed chromatographic conditions complete separation of DZP, benzyl al-
cohol and benzoic acid/sodium benzoate was obtained. Retention times were 2.16, 2.66
and 8.30 min for benzyl alcohol, benzoic acid/sodium benzoate and DZP, respectively.
The obtained values of capacity factor k' (1 < k' < 10), selectively factor  ( >1) and re-
solution factor Rs (Rs >2) showed that the proposed chromatographic conditions are
suitable for quantitative separation and determination of the analyzed components. Fur-
ther, in the chromatogram of blank solution there are no interfering peaks at the reten-
tion times of investigated peaks, which indicates that the method is selective and could
be used for identification and simultaneous quantification of DZP, benzyl alcohol and
benzoic acid/sodium benzoate.
Validation data of the HPLC method demonstrated that the proposed method was
selective, linear, precise and accurate (19). Calibration curves fitted for DZP, benzyl alco-
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Table II. Physicochemical parameters of freshly prepared DZP rectal hydrogelsa
Hydrogel pHb Viscosity (Pa s)b Diazepam (%)c Preservative (%)c
HG1 7.16 ± 0.04 2.10 ± 0.05 110.50 ± 0.06 99.90 ± 0.06
HG2 7.12 ± 0.06 2.10 ± 0.07 106.80 ± 0.05 99.30 ± 0.08
HG3 7.21 ± 0.02 2.05 ± 0.09 103.83 ± 0.08 99.80 ± 0.05
a Mean ± SD.
b n = 3.
c n = 5.
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Fig. 1. Chromatograms of: a) standard solution of DZP (0.05 mg mL–1), benzyl alcohol (0.375 µg
mL–1), benzoic acid (0.025 µg mL–1) and sodium benzoate (0.05 µg mL–1); b) blank solution without
DZP, benzyl alcohol, benzoic acid and sodium benzoate, and c) sample solution of DZP (0.05 mg





hol, benzoic acid/sodium benzoate gave correlation coefficients above 0.9996. The rela-
tive standard deviation (RSD) for inter-day analysis was 0.9, 0.4 and 1.7% for DZP, ben-
zyl alcohol and benzoic acid/sodium benzoate, respectively. The accuracy of the method
was confirmed by the standard addition method and the obtained analytical recoveries
were 99.6–100.9% for DZP, 98.6–100.7% for benzyl alcohol, and 98.4–99.5% for benzoic
acid/sodium benzoate.
Rheological studies. – Viscosity of rectal gels is an important factor, which affects the
rate of drug release, distribution of the gel in the distal portion of the large intestine as
well as its retention time. Literature data suggest that the viscosity of rectal gels should be
in a range of 1–2 Pa s. (26). The prepared formulations exhibited pseudoplastic rheology,
as evidenced by shear thinning and an increase in the shear stress with increased angu-
lar velocity. The gel structure is composed of random oriented molecules in the form of
long chains. Dynamic viscosity of the prepared formulations was 2 Pa s. No change in
the viscosity was observed by measuring the samples at different temperatures (23 °C
and 37 °C). These results were important for the formulation stability in terms of observ-
ing the changes in the rheological behaviour of the formulations during the stress condi-
tions and to determine the rheological status of the prepared delivery systems after ap-
plication in the rectum. In Figs. 2 and 3 flow curves and viscosity curves for sample
HG3, measured at temperature of 37 °C, are presented.
In vitro drug release studies. – Profiles of drug release from rectal hydrogel formula-
tions are presented in Fig. 4. Diazepam was fully released from the prepared formula-
tions within a period of 3 h. As can be seen, formulation HG3 initially showed a faster
release rate ( 50% in the first half an hour) than formulations HG2 and HG1 (50% after
the first hour). The main reason for the observed effect might be the higher concentra-
tion gradient being responsible for a more efficient diffusion of the drug molecules through
the hydrogel phase, while all other conditions were the same. Hence, changing the drug
loading offers a real possibility of controlling the drug release (13).
To study the drug release mechanism, the release data were fitted to the general ex-
ponential function: Mt/M0 = ktn where M0 is the initial amount of DZP (amount of DZP
released at time zero) and Mt is the amount of DZP released at time t, n is a diffusion ex-
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Fig. 2. Comparative flow
curves for sample HG3,
freshly prepared and af-
ter 1 month storage at 37
°C (mean ± SD, n = 3).
ponent characteristic of the release mechanism, and k denotes the properties of the poly-
mer and the drug (15). According to Brazel and Peppas (20), this equation has been fre-
quently used in the literature owing to its utility in describing the relative importance of
Fickian (n = 0.5) and non-Fickian, anomalous diffusion (n  1.0). If the exponent n is
around 0.5, the drug release is represented by a square root equation; if n = 1, the frac-
tional release is of zero-order. Values of n greater than 0.5 indicate anomalous diffusion,
generally due to the swelling of the system in the solvent before the release takes place.
Exponential dependence of the amount of DZP released on time was evidenced; the
diffusion exponents were 0.5, 0.55 and 0.47 for formulations HG1, HG2 and HG3, re-
spectively, confirming that the mechanism of drug release from HPMC hydrogels in-
volves diffusion through the elastic gel matrix. Good linear relationship was obtained
between the cumulative percentage of released DZP and the square root of time (27).
Drug release constants k and correlation coefficients R for the mathematical model of
diffusion are presented in Table III.
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Fig. 3. Comparative viscosity curves for sample HG3, freshly prepared and after 1 month storage at





























Fig. 4. Release profiles of DZP from
rectal hydrogels HG1, HG2 and HG3;
each point represent the mean ± SD,
n = 3.
Preservatives efficacy and microbiological analysis. – Considering the DZP rectal gel for-
mulations, the success criterion of the preservatives used (combination of sodium ben-
zoate, benzyl alcohol and benzoic acid) was satisfied (18). Regarding the microbiological
quality, the prepared formulations complied with the standards proposed by the Euro-
pean Pharmacopoeia (18).
Stability. – After 4 months of storage at 26 ± 0.5 °C, no significant changes in the
physicochemical properties of the prepared formulations were observed (for pH value
of the gels F was 0.65, for DZP content F was 2.67 and for preservatives content F was
5.31; Fcrit. = 7.70, p < 0.05).
By maintaining the preparations at a temperature of 37 °C, after 1 month storage,
significant changes in DZP content and viscosity (Figs. 2, 3) were observed (p < 0.05).
These results are in agreement with the earlier findings, that in storage conditions above
30 °C, the commercially available DZP rectal gel (Diastat) was stable for 30 to 60 days
(28). When storing the formulations at a temperature of 2–8 °C, the physical status of the
formulations changed (the drug substance precipitated) after one week. These findings
point to the necessity of further investigations to obtain formulations of better stability
for a broaden application, especially in regions where the temperature deviates from the
mean temperature characteristic of the 2nd climate zone.
Prepared DZP delivery systems should be stored at a room temperature of 15–30 °C,
protected from light and moisture, and should be used within a period of 4 months.
CONCLUSIONS
The HPMC hydrogels containing various concentrations of DZP intended for rectal
administration have been prepared and evaluated. It can be summarized that the pre-
pared formulations showed satisfactory solubility of DZP, adequate rheological charac-
teristics, release behaviour and microbiological quality. Under the conditions character-
istic of the second climate zone, the dosage forms were stable for a period of 4 months.
Further investigations will be focused on modification of the formulation for the pur-
pose of achieving better stability of the DZP rectal delivery system.
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Table III. Kinetic parameters for DZP hydrogel formulations (n = 3)
Hydrogel n ± SDa
Higuchi diffusion model
R k ± SD (mg h–1/2)
HG1 0.50 ± 0.07 0.990 1.34 ± 0.20
HG2 0.55 ± 0.04 0.997 2.67 ± 0.12
HG3 0.47 ± 0.05 0.990 2.90 ± 0.19
a The release exponent n obtained from equation Mt/M0 = ktn.
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S A @ E T A K
Priprava i evaluacija hidrogela s diazepamom za rektalnu primjenu
MARIJA GLAVAS DODOV, KATERINA GORACINOVA, MAJA SIMONOSKA, SUZANA TRAJKOVIC-JOLEVSKA,
JASMINA TONIC RIBARSKA i MARIJA DASTEVSKA MITEVSKA
Diazepam (DZP) je ljekovita tvar koja se upotrebljava u terapiji akutnih epilepti~kih
napada i febrilnih konvulzija u djece. U radu je opisana priprava i evaluacija hidrogela
za rektalnu primjenu s diazepamom i odgovaraju}im pomo}nim tvarima i konzervan-
sima. Pripravci su sadr`avali razli~ite koncentracije DZP (2, 4 i 6 mg mL–1). Njihova fi-
zi~ko-kemijska svojstva (pH vrijednost, sadr`aj ljekovite i pomo}nih tvari, viskoznost),
antimikrobna u~inkovitost i mikrobiolo{ka ~isto}a bili su zadovoljavaju}i. Razvijena je
HPLC metoda kojom je postignuta separacija DZP i konzervansa. In vitro ispitivanja su
pokazala da se cjelokupna koli~ina DZP oslobodi tijekom 3 h. Pripravci su bili stabilni 4
mjeseca na temperaturi 26 °C (sobna temperatura karakteristi~na za 2. klimatsku zonu).
Klju~ne rije~i: diazepam, HPMC hidrogel, rektalna primjena, HPLC odre|ivanje, stabilnost
Department of Pharmaceutical Technology, Faculty of Pharmacy, University »Ss Cyril and Methodious«,
1000 Skopje, Macedonia
Department of Quality Control, Faculty of Pharmacy, University »Ss Cyril and Methodious«, 1000
Skopje, Macedonia
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